Open payments is open for business. How has your experience been so far?

Fenoldopam was found to be ineffective at reducing risks for renal replacement therapy in cardiovascular patients with acute kidney injury (AKI), according to a study published Sept. 29 in JAMA. It was also ineffective at reducing risk of death over placebo.

Chronic kidney disease (CKD) was not an indicator of increased bleeding risk in stroke patients treated with intravenous thrombolysis, according to a study published online Sept. 23 in Circulation: Cardiovascular Quality and Outcomes. The research team did note that stroke patients with CKD did have increased risks for poorer outcomes, however.

Obstructive sleep apnea increased rates of postoperative cardiac events, according to a study published in the October issue of Anesthesiology.

The FDA warned that the asthma drug omalizumab slightly increases the risk of cardiovascular and cerebrovascular events in patients treated with the medicine.

Guidelines on chest compressions for cardiac arrest may be encouraging well-meaning aid to push too far. Out-of-hospital cardiac arrest patients had best outcomes with a chest compression depth between 40.3 and 55.3 mm, according to findings published online Sept. 24 in Circulation.

A cardiologist in Georgia agreed to pay $200,000 to settle a longstanding kickback case, the Atlanta U.S. Attorney’s Office announced.

How avidly do clinicians follow guidelines? Perhaps only to the degree that their worth is apparent and appreciated.